Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:CASNumber |
1058137-23-7
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Servier_Laboratories
gptkb:Clovis_Oncology |
| gptkbp:hasMolecularFormula |
C26H25FN6O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lucitanib
|
| gptkbp:investigatedBy |
gptkb:cancer
solid tumors |
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:molecularWeight |
504.5 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2105727
25154816 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
ALM-201
E-3810 |
| gptkbp:target |
gptkb:FGFR1
gptkb:VEGFR1 gptkb:VEGFR2 gptkb:PDGFRβ gptkb:FGFR2 gptkb:PDGFRα gptkb:VEGFR3 |
| gptkbp:UNII |
2Z2S3V3A7B
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:CD332
|
| gptkbp:bfsLayer |
7
|